MedPath

Efficacy and Safety of High Dose Intravenous Iron for Correcting Anemia and Reducing Blood Transfusion in Patient Undergoing Hysterectomy: Retrospective Cohort Study

Recruiting
Conditions
patients undergoing hysterectomy who have iron deficiency anemia
iron deficiency anemia, hysterectomy, patients undergoing hysterectomy
Registration Number
TCTR20240422011
Lead Sponsor
Faculty of Medicine Khon Kaen University Research Fund
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
124
Inclusion Criteria

1. Patients diagnosed with uterine tumor and/or abnormal vaginal bleeding such as Leiomyoma, Adenomyosis, Endometrial hyperplasia, heavy menstrual bleeding, etc.
2. Patients who had hysterectomy at Srinakarind Hospital during 1 January 2020 to 31 August 2023.
3. Patients older than or equal to 20 years old.
4. Patients with blood concentration values less than 12 (Hb < 12 g/dL)

Exclusion Criteria

1.Patients who have been diagnosed with cancer
2.Patients who have undergone surgery and lost more than 1,000 ml of blood
3.Patients with chronic diseases such as thalassemia anemia, blood-dependent type
4.Patients with anemia due to abnormal bone marrow function
5.Patients who receive chemotherapy
6.Patients with Ferritin > 800 ng/mL
7.Patients with transferrin saturation (TSAT) more than and equal 50%
8.Patients with incomplete or missing records and medical history

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
blood transfusion rate intra-op, post-op in admission blood transfusion
Secondary Outcome Measures
NameTimeMethod
hemoconcentration pre-op, post-op Hb, Hct post treatment
© Copyright 2025. All Rights Reserved by MedPath